Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

ITabMed Formed as JV to Develop T Cell Engagers; Raises $20 Million

publication date: Dec 1, 2021

Shanghai ITabMed announced it has completed the spin-off from Evive Biotech of the iTAb™ (immunotherapy antibody) platform and closed a $20 million Series A-round financing. Earlier this year, Evive (formerly Generon BioMed) and Dr. Xiaoqiang Yan formed ITabMed as a joint venture with full support from Evive. The JV will focus on continued development of oncology immunotherapies derived from the iTAb™ platform, which generates bi- or tri-specific T cell engagers. The company has started Phase I trials of two products while other iTAb drug candidates are in preclinical development. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here